Future studies on DRD2 and the cAMP signal pathway in ONC201-treated CTCL cells may help us disclose the mechanism(s) of action of ONC201 on CTCL. Here, DRD2 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.